# Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer

> **NCT00003704** · PHASE1 · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 51 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** capecitabine
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00003704
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-04
- **Primary completion:** 2003-07
- **Final completion:** 2003-07
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2016-07-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003704, "Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00003704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*